ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
0.00 (0.00%)
Sep 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 41.52 - 57.34
Open     -
Vol / Avg. 0.00/689,579.00
Mkt cap 6.91B
P/E 20.50
Div/yield 0.28/2.27
EPS 2.40
Shares 140.17M
Beta 0.78
Inst. own 55%
Oct 22, 2014
Q1 2015 ResMed Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Sep 11, 2014
ResMed Inc at Bank of America Merrill Lynch Australian Investment Conference
Jul 31, 2014
Q4 2014 ResMed Inc Earnings Call - Webcast
Jul 31, 2014
Q4 2014 ResMed Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 21.13% 22.20%
Operating margin 23.72% 26.05%
EBITD margin - 31.18%
Return on average assets 14.89% 15.10%
Return on average equity 20.41% 20.50%
Employees 4,100 -
CDP Score - 45


9001 Spectrum Center Blvd.
United States - Map
+1-858-7462400 (Phone)
+1-858-8365501 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ResMed Inc., (ResMed) is a holding company for the ResMed Group. The Company, through its subsidiaries, is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB) includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. The Company has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. Its manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States. Its distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. In December 2013, ResMed Inc acquired Unimedis SRO, a surgical appliance and manufacturing company.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 41
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Don Darkin President - Sleep-disordered Breathing Strategic Business Unit
Age: 60
Bio & Compensation  - Reuters
Jim Hollingshead President - Americas
Age: 50
Bio & Compensation  - Reuters
Anne Reiser President, Europe
Age: 52
Bio & Compensation  - Reuters
David Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Constance Bienfait Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 66
Bio & Compensation  - Reuters